Influence of althesin on coronary blood flow and myocardial oxygen consumption in dogs.
D000771:Anesthesia, Intravenous; D000777:Anesthetics / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002368:Castor Oil; D003326:Coronary Circulation / Q000187:drug effects*; D003864:Depression, Chemical; D004285:Dogs; D004338:Drug Combinations; D005027:Ethylene Oxide; D006339:Heart Rate / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D006914:Hydroxysteroids / Q000008:administration & dosage / Q000494:pharmacology; D007275:Injections, Intravenous; D007668:Kidney / Q000098:blood supply; D009206:Myocardium / Q000378:metabolism*; D009609:Nitrous Oxide; D010100:Oxygen; D010101:Oxygen Consumption / Q000187:drug effects*; D014677:Pharmaceutical Vehicles; D010880:Piperidines / Q000008:administration & dosage; D011277:Pregnanediones / Q000008:administration & dosage / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D013268:Stimulation, Chemical; D013501:Surface-Active Agents; D013997:Time Factors
D000777:Anesthetics; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D006914:Hydroxysteroids; D014677:Pharmaceutical Vehicles; D010880:Piperidines; D011277:Pregnanediones; D013501:Surface-Active Agents; D002368:Castor Oil; D005027:Ethylene Oxide; D009609:Nitrous Oxide; D010100:Oxygen